PCSK9 and metabolic dysfunction-associated steatotic liver disease: Given that disturbed cholesterol metabolism is often associated with different etiologies linked to chronic liver dysfunction, including obesity, insulin resistance, type 2 diabetes, NAFLD, as well as viral infections and liver cancers, it will be important to clarify if PCSK9 inhibition counteracts or contributes to pathophysiology in chronic liver diseases.